(Press-News.org) (LOS ANGELES) – February 29, 2024 - The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce their selections of Assistant Professors Amir Manbachi of Johns Hopkins University and Ritu Raman of the Massachusetts Institute of Technology (MIT) as the recipients of the 2024 Hisako Terasaki Young Innovator Awards. The awards will be presented at TIBI’s 2nd annual Terasaki Innovation Summit, to be held March 27-29, 2024, at the UCLA Meyer & Renee Luskin Conference Center.
The award was created in memory of Hisako Terasaki, philanthropist, accomplished artist, and wife of Dr. Paul I. Terasaki, a pioneer in organ transplant research and innovation. It recognizes early-career scientists who have made significant contributions to biomedical science by creating novel or markedly improved technologies which show great promise for high-impact translation. This year’s award recipients were stellar candidates, chosen for their extraordinary accomplishments and prolific scientific contributions during their young academic careers.
Amir Manbachi, Ph.D.
In addition to being Assistant Professor in several departments at Johns Hopkins University, Dr. Amir Manbachi is also the Co-Director of the university’s collaborative HEPIUS Innovation Lab, a design innovation hub for spinal cord injury. In establishing his laboratory, Dr. Manbachi leveraged his expertise in ultrasound technology for diagnostics and therapeutics, as well as his exemplary ability to bring together collaborators from clinical, academic, and industrial realms. Through his efforts, Dr. Manbachi was able to develop an ultrasonic toolkit for spinal surgery, which enables augmented imaging for surgical navigation, a research area which continues to evolve. This technology has also been applied to work in glioma/neurosurgery, as well as in the regulation and classification of blood vessels.
As he’s risen quickly in his career trajectory at Johns Hopkins, Dr. Manbachi has also used his talents for translational research and entrepreneurial innovation, and this has produced high-impact technology supported by top-notch funding from the NIH, National Science Foundation (NSF), and the Department of Defense (DOD). While still in the early years of his career, he received multiple such awards, including a $13.48 million DOD contract.
He has also been well received by his peers and mentees for his award-winning leadership and managerial skills, and currently leads a research team of approximately 70 individuals.
In his relatively short professional career, Dr. Manbachi has truly exhibited all the qualities needed to translate high-impact biomedical innovations into the real world, and TIBI is pleased to recognize him as a Hisako Terasaki Young Innovator Award recipient.
Ritu Raman, Ph.D.
From her years as a Ph.D. student and postdoctoral fellow to her current position as Assistant Professor of Mechanical Engineering at MIT, Dr. Ritu Raman has exhibited exceptional talent in creating novel and inventive solutions to the most challenging biomedical needs.
While still a Ph.D. student, she developed methods for tissue engineering of light-sensitive neuromuscular skeletal muscle for soft robotics, as well as protocols for 3D printing and cryopreservation used in high-throughput manufacturing of engineered muscle. These bodies of work not only produced high-impact papers and articles but garnered awards and special recognitions.
After she subsequently obtained multiple fellowships, she worked as a postdoctoral researcher and eventually developed an independent research program under Professor Robert Langer at MIT, where she addressed the most critical challenges of the university’s efforts in drug delivery and biomedical sensing. Drawing on her previous experience with light-sensitive biomaterials, Dr. Raman developed a novel light-degradable hydrogel which could activate and interface with implantable devices; this hydrogel had the doubly unique capability of degradation using non-invasive ingestible LEDs.
In another project, Dr. Raman developed a novel implantable microfluidic pump which uses a heat-sensitive alloy to modulate nanoliter fluid delivery to highly specific regions of the brain. This groundbreaking technology can also be used for extracting micro-invasive liquid biopsies in deep brain structure – an unprecedented feat.
Dr. Raman is currently working on a variety of well-funded projects to reach her goal of using tissue engineered muscle to treat diseases of human mobility. These projects spotlight unique approaches, involving light-sensitive tissue engineered muscle and different platforms for stimulating muscular motion, assembly, and growth.
In addition to her research, Dr. Raman has been a prolific author and mentor to over 44 trainees, and she has been active in promoting access to STEM education for women and underrepresented minorities.
TIBI is excited to bestow the Hisako Terasaki Young Innovator Award upon Dr. Raman for her exceptional creativity and innovation, as well as for her excellence in achievement and productivity.
“Much as my parents’ passion for their chosen fields has influenced their lives and those of others, these young scientists have greatly impacted the health and well-being of countless people,” said Keith Terasaki, M.D., TIBI’s Chairman of the Board and son of Hisako and Dr. Paul Terasaki. “It gives me great pleasure to recognize them for their outstanding accomplishments.”
###
About the Terasaki Institute for Biomedical Innovation
The Terasaki Institute for Biomedical Innovation is accelerating the pace of translational research by supporting the world’s leading scientists with an open, entrepreneurial environment for bioengineering new materials, biological models, and advanced technologies to address critical challenges to the health of the planet and its people. The Institute’s worldwide collaborations with academic, clinical, and entrepreneurial partners provide a rich foundation for translating innovations to the real world.
Contact:
Stewart Han
President
Terasaki Institute for Biomedical Innovation
shan@terasaki.org
END
Terasaki Institute for Biomedical Innovation announces 2024 Hisako Terasaki Award recipients
2024-02-29
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Small dietary changes can cut your carbon footprint by 25%
2024-02-29
The latest Canada’s Food Guide presents a paradigm shift in nutrition advice, nixing traditional food groups, including meat and dairy, and stressing the importance of plant-based proteins. Yet, the full implications of replacing animal with plant protein foods in Canadians’ diets are unknown.
New research at McGill University in collaboration with the London School of Hygiene & Tropical Medicine provides compelling evidence that partially substituting animal with plant protein foods can increase life expectancy and decrease greenhouse gas emissions. Importantly, ...
Uncertainty in measuring biodiversity change could hinder progress towards global targets for nature
2024-02-29
More than ever before, there is a growing interest in dedicating resources to stop the loss of biodiversity, as recently exemplified by the Kunming-Montreal Global Biodiversity Framework (GBF) decided at COP15 in December 2022. The GBF focuses on understanding why biodiversity is declining and what actions are needed to reverse this trend. However, according to researchers at McGill University, implementing the plan is challenging because information about biodiversity changes is not evenly available everywhere, and is uncertain in many places.
With the available data, can the ...
Zero emissions of carbon dioxide! Successful production of ammonia-based clean hydrogen
2024-02-29
Dr. Jung Unho's research team at the Hydrogen Research Department of the Korea Institute of Energy Research (KIER) has developed Korea's first clean hydrogen production technology. This technology is based on ammonia decomposition and does not use fossil fuels. The team's breakthrough could pave the way for a more sustainable and eco-friendly energy source. This allows for the production of high-purity hydrogen that meets international standards for hydrogen-powered vehicles, without the carbon dioxide emissions produced by using fossil fuels.
Ammonia, a compound of hydrogen and nitrogen, has a hydrogen storage density 1.7 times ...
Guiding future research on ‘extraordinary potential’ of next-generation solar cells
2024-02-29
Today’s commercial solar panels can convert about 15% to 20% of the sunlight they absorb into electrical energy — but they could be much more efficient, according to researchers at Soochow University. The next generation of solar cells has already demonstrated 26.1% efficiency, they said, but more specific research directions are needed to make such efficiency the standard and expand beyond it.
They published their review of the current state of research on high-efficiency perovskite solar cells and their recommendations for future work in Energy Materials and Devices on February 4.
“Metal halide perovskite ...
Urgent need for guidelines for the care of child victims of sexual abuse
2024-02-29
Only half of 34 surveyed European countries have national guidelines on how to provide clinical care and treatment to children who have experienced sexual abuse. This finding was revealed in a study led by researchers at Barnafrid, a national knowledge centre in the field of violence and other abuse against children, at Linköping University in Sweden. The consequences for the affected children can be severe, according to the researchers.
“Our findings suggest that children in Europe may not receive equal care. From a child rights perspective, this is unacceptable. ...
Overcoming barriers to conducting clinical trials in childhood rare disease research
2024-02-29
Using a novel methodology, researchers at The Hospital for Sick Children (SickKids) are the first in paediatric research to use data from an international real-world cohort to overcome the barriers associated with conducting randomized clinical trials in children with rare diseases.
The gold standard for evaluating new therapeutics is through randomized clinical trials, where one group of individuals receives treatment while another does not. Unfortunately, conducting this type of clinical trial proves challenging for many rare conditions due to the limited number of individuals with the condition, making meaningful comparisons difficult. Additionally, ...
Faster and simpler point-of-care malaria test developed by Rice researchers
2024-02-29
Rice University researchers have developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests. The advancement has the potential to improve patient outcomes, especially in rural regions with limited health care resources.
Malaria remains a significant global health challenge with an estimated 247 million cases and more than 600,000 deaths annually, the majority of which occur in sub-Saharan Africa. The most severe form, cerebral malaria, has a high mortality ...
Investigating cell killers: Advanced system for size-dependent cytotoxicity analysis of silica
2024-02-29
Metal nanomaterials have become an indispensable part of industrial and medical fields due to their unique and versatile properties. Their size, which imparts them with the desired physiochemical properties, is also the reason for environmental and health concerns. The nano-sized particles in nanomaterials have shown high reactivity towards biomolecules and often even toxicity towards biological cells.
Scientists have attributed this behavior of metal nanoparticles in interaction with biomolecules to phenomena like inflammation or oxidative stress. However, to ensure the safe usage of metal nanoparticles, ...
Poor spatial navigation could predict Alzheimer’s disease years before the onset of symptoms
2024-02-29
People at risk of Alzheimer’s disease have impaired spatial navigation prior to problems with other cognitive functions, including memory, finds a new study led by UCL researchers.
The research, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, used virtual reality to test the spatial navigation of 100 asymptomatic midlife adults, aged 43-66, from the PREVENT-Dementia prospective cohort study.
Participants had a hereditary or physiological risk of Alzheimer’s disease, due to either a gene (the APOE-ε4 allele) that puts them at risk of the condition, a family history of Alzheimer’s disease, ...
Black mountain unveils fossil trove
2024-02-29
A team of researchers led by Alexander Pohle has unveiled a treasure trove of ancient fossils from Queensland's Black Mountain. The findings, published in PeerJ Life & Environment, shed new light on the complex three-dimensional siphuncle morphology of Plectronoceratids, a pivotal group of molluscs from the latest Cambrian period.
The study surpasses the entirety of previously documented Plectronoceratid fossils, presenting over 200 well-preserved specimens. These fossils, meticulously collected by the late Mary Wade and her team during the 1970s and 1980s, offer unprecedented insights into the intricate structures of these ancient creatures.
Pohle's team focused on specimens ...